跳至主要内容
临床试验/NCT02665533
NCT02665533已完成不适用

Evaluation of Two Pharmacological Protocols for Pre-emptive Analgesia in Impacted Third Molar Surgery

Federal University of the Valleys of Jequitinhonha and Mucuri1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2016年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
18
试验地点
1
主要终点
Post-surgical swelling of third molar extraction determined using linear measures in the face

研究概览

简要总结

The main aim of the study is to investigate the pre-emptive effect of dexamethasone and diclofenac associated to codeine to prevent the pain, edema and limited mouth opening at the extraction of third molar.

详细描述

The surgery of third molar is usually associated with important post-surgical sequelae. The damage caused to tissue and bone may result in considerable pain, edema and trismus. The symptoms start gradually, peaking in 2 days after the extraction. The use of medications such as dexamethasone and diclofenac associated to codeine may support the prevention of post-surgical pain. This clinical trial aim compare the the pre-emptive effect of dexamethasone and diclofenac associated to codeine to prevent the pain, edema and limited mouth opening at the extraction of third molar.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with indication of asymptomatic bilateral extractions of lower third molars;
  • Aged 18 years or older;
  • Have a good health and no disease;

排除标准

  • Patients with history of any medication treatment within 15 days before the beginning of the research, history of allergy to the drugs, substances or materials used in this study, pregnancy or lactation.

研究组 & 干预措施

Dexamethasone

Active Comparator

Dexamethasone 8 mg, one capsule single preoperative dose.

干预措施: Dexamethasone (Drug)

Diclofenac Sodium associated with Codeine

Experimental

Diclofenac Sodium 50 mg associated with Codeine 50 mg, one capsule single preoperative dose.

干预措施: Diclofenac Sodium associated with Codeine (Drug)

结局指标

主要结局

Post-surgical swelling of third molar extraction determined using linear measures in the face

时间窗: Up to seven days post-surgical

During the post-surgical intervals of 24, 48 and 72 hours and seven days, the swelling was determined using linear measures in the face.

Post-surgical trismus of third molar extraction determined by maximum mouth opening

时间窗: Up to seven days post-surgical

During the post-surgical intervals of 24, 48 and 72 hours and seven days, the trismus was determined by maximum mouth opening.

Post-surgical pain of third molar extraction using visual analogic scale

时间窗: Up to seven days post-surgical

The post-surgical pain was self-recorded by the patient using visual analogic scale in intervals of 24, 48 and 72 hours and seven days.

次要结局

  • Analgesic consumption(Up to seven days post-surgical)
  • Duration of surgery(Up to seven days post-surgical)

研究者

发起方
Federal University of the Valleys of Jequitinhonha and Mucuri
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

已完成
2 期
Dexamethasone and Etoricoxib for Pain Prevention Following Periodontal SurgeryPain Control
NCT00970112Universidade Estadual de Ponta Grossa20
已完成
3 期
Phase III Randomized, Double-Blind Study of Dexamethasone Vs Dexamethasone/Methylprednisolone Vs Placebo for Bronchopulmonary DysplasiaBronchopulmonary Dysplasia
NCT00004785National Center for Research Resources (NCRR)54
已完成
不适用
Effect of Dexamethasone and Methylprednisolone on Pain, Swelling and Trismus After Third Molar SurgeryPain,Edema,Trismus
NCT01603498Federal University of the Valleys of Jequitinhonha and Mucuri18
终止
2 期
Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation TherapyNausea and VomitingStage III Squamous Cell Carcinoma of the HypopharynxStage III Squamous Cell Carcinoma of the LarynxStage III Squamous Cell Carcinoma of the Lip and Oral CavityStage III Squamous Cell Carcinoma of the NasopharynxStage III Squamous Cell Carcinoma of the OropharynxStage IV Squamous Cell Carcinoma of the HypopharynxStage IV Squamous Cell Carcinoma of the LarynxStage IV Squamous Cell Carcinoma of the Lip and Oral CavityStage IV Squamous Cell Carcinoma of the NasopharynxStage IV Squamous Cell Carcinoma of the Oropharynx
NCT00895245University of Washington6
已完成
2 期
Eltrombopag and High-dose Dexamethasone as First Line Treatment for ITImmune Thrombocytopenic Purpura
NCT01652599Hospital Universitario Dr. Jose E. Gonzalez30